PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22554165-8	2012	RESULTS: The assay was developed for quantitation of a single EGFR tryptic peptide for use in FFPE patient tissue with absolute specificity to uniquely distinguish EGFR from all other proteins including the receptor tyrosine kinases, IGF-1R, cMet, Her2, Her3, and Her4.	Peptides	75-82	epidermal growth factor receptor	Homo sapiens	62-66	
22554165-8	2012	RESULTS: The assay was developed for quantitation of a single EGFR tryptic peptide for use in FFPE patient tissue with absolute specificity to uniquely distinguish EGFR from all other proteins including the receptor tyrosine kinases, IGF-1R, cMet, Her2, Her3, and Her4.	Peptides	75-82	epidermal growth factor receptor	Homo sapiens	164-168	
34633106-9	2022	Introducing cell-penetrating peptides or Arginine-9 (Arg9) at the N-terminus of NP1 thus improves cell-penetrability and can lead to the inhibition of EGFR-driven cancer cell lines; however, it exhibits no hepatotoxicity.	Peptides	29-37	epidermal growth factor receptor	Homo sapiens	151-155	
19289054-6	2009	Importantly, computational estimations of binding affinities show that EGFR-derived phosphotyrosyl peptides bind with significantly more strength to unphosphorylated than to phosphorylated Shc.	Peptides	99-107	epidermal growth factor receptor	Homo sapiens	71-75	
12948142-4	2003	This tyrosine-targeted tandem mass spectrometry strategy is demonstrated for epidermal growth factor receptor showing that phosphotyrosine-containing tryptic peptides invisible in the survey spectrum can be safely identified.	Peptides	158-166	epidermal growth factor receptor	Homo sapiens	77-109	
33310044-0	2021	Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells.	Peptides	55-63	epidermal growth factor receptor	Homo sapiens	15-19	
2418017-12	1986	Tryptic peptide maps suggest that antibody 2913 and EGF stimulate phosphorylation of the same amino acid residues.	Peptides	8-15	epidermal growth factor receptor	Homo sapiens	52-55	
2543678-9	1989	Direct microsequencing of a phosphorylated tryptic peptide from the human EGF receptor confirmed this assignment.	Peptides	51-58	epidermal growth factor receptor	Homo sapiens	74-86	
32530018-0	2020	Amphiphilic drug-peptide-polymer conjugates based on poly(ethylene glycol) and hyperbranched polyglycerol for epidermal growth factor receptor targeting: the effect of conjugate aggregation on in vitro activity.	Peptides	17-24	epidermal growth factor receptor	Homo sapiens	110-142	
33498632-5	2021	Surface plasmon resonance (SPR) results show binding affinity of the three BODIPY-peptide conjugates for EGFR, particularly for 5 bearing the cyclic peptide.	Peptides	82-89	epidermal growth factor receptor	Homo sapiens	105-109	
31752491-0	2019	De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor.	Peptides	41-49	epidermal growth factor receptor	Homo sapiens	66-98	
31222504-7	2019	RESULTS: For final eGFR, 16 proteins and 30 metabolites or tryptic peptides showed significant association in SDRNT1BIO, and nine proteins and five metabolites or tryptic peptides in FinnDiane, beyond age, sex, diabetes duration, study day eGFR and length of follow-up (all at p < 10-4).	Peptides	67-75	epidermal growth factor receptor	Homo sapiens	19-23	
31222504-7	2019	RESULTS: For final eGFR, 16 proteins and 30 metabolites or tryptic peptides showed significant association in SDRNT1BIO, and nine proteins and five metabolites or tryptic peptides in FinnDiane, beyond age, sex, diabetes duration, study day eGFR and length of follow-up (all at p < 10-4).	Peptides	67-75	epidermal growth factor receptor	Homo sapiens	240-244